The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel. (Q43643458)
Jump to navigation
Jump to search
scientific article published in June 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel. |
scientific article published in June 2001 |
Statements
The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel (English)
S E Bates
T Fojo
M V Blagosklonny
W D Figg
D Liewehr